Beijing (1)

HER2 Positive Solid Tumor (1)

Recruiting (1)

phase 1 (1)

Peking University (1)

Jiangsu Alphamab Biopharmaceuticals Co., Ltd (1)

kn026 combined with kn046 (1)

biological (1)

Other (1)

Interventional (1)

her2 positive solid tumor

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Apr 6, 2022